Kyu Hun Choi

5.8k total citations
190 papers, 4.2k citations indexed

About

Kyu Hun Choi is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kyu Hun Choi has authored 190 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Nephrology, 35 papers in Pulmonary and Respiratory Medicine and 30 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kyu Hun Choi's work include Dialysis and Renal Disease Management (50 papers), Renal Diseases and Glomerulopathies (33 papers) and Chronic Kidney Disease and Diabetes (31 papers). Kyu Hun Choi is often cited by papers focused on Dialysis and Renal Disease Management (50 papers), Renal Diseases and Glomerulopathies (33 papers) and Chronic Kidney Disease and Diabetes (31 papers). Kyu Hun Choi collaborates with scholars based in South Korea, United States and Canada. Kyu Hun Choi's co-authors include Shin‐Wook Kang, Tae‐Hyun Yoo, Seung Hyeok Han, Dae Suk Han, Ho Yung Lee, Jung Tak Park, Beom Seok Kim, Hyeon Joo Jeong, Hyung Jung Oh and Mi Jung Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kyu Hun Choi

185 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyu Hun Choi South Korea 36 2.6k 763 705 522 468 190 4.2k
Austin G. Stack Ireland 28 3.2k 1.2× 576 0.8× 787 1.1× 922 1.8× 337 0.7× 79 4.4k
M. Kessler France 35 1.9k 0.7× 850 1.1× 1.2k 1.7× 536 1.0× 654 1.4× 218 5.2k
Vedat Schwenger Germany 37 1.7k 0.6× 787 1.0× 1.3k 1.8× 660 1.3× 448 1.0× 197 4.6k
Charles A. Herzog United States 28 3.0k 1.2× 957 1.3× 695 1.0× 1.1k 2.1× 223 0.5× 48 4.4k
Sunil V. Badve Australia 37 2.2k 0.9× 653 0.9× 960 1.4× 522 1.0× 235 0.5× 152 3.9k
Jeffrey S. Berns United States 36 2.0k 0.8× 774 1.0× 481 0.7× 269 0.5× 291 0.6× 139 4.2k
Kathleen Claes Belgium 38 2.1k 0.8× 963 1.3× 844 1.2× 244 0.5× 284 0.6× 115 4.2k
Diana C. Grootendorst Netherlands 31 1.6k 0.6× 1.1k 1.4× 444 0.6× 411 0.8× 341 0.7× 66 3.9k
Jennifer Gassman United States 38 3.2k 1.2× 1.2k 1.6× 867 1.2× 1.0k 1.9× 312 0.7× 77 5.0k
Ryan D. Kilpatrick United States 24 2.8k 1.1× 397 0.5× 690 1.0× 383 0.7× 311 0.7× 51 4.2k

Countries citing papers authored by Kyu Hun Choi

Since Specialization
Citations

This map shows the geographic impact of Kyu Hun Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyu Hun Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyu Hun Choi more than expected).

Fields of papers citing papers by Kyu Hun Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyu Hun Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyu Hun Choi. The network helps show where Kyu Hun Choi may publish in the future.

Co-authorship network of co-authors of Kyu Hun Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Kyu Hun Choi. A scholar is included among the top collaborators of Kyu Hun Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyu Hun Choi. Kyu Hun Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Kyu Hun, et al.. (2025). Minimal Intraoperative Anticoagulation Protocol for Lung Transplantation with Heparin-Induced Thrombocytopenia. The Journal of Heart and Lung Transplantation. 44(4). S680–S680.
3.
Lee, Mi Jung, Jung Tak Park, Tae Ik Chang, et al.. (2021). Smoking Cessation and Coronary Artery Calcification in CKD. Clinical Journal of the American Society of Nephrology. 16(6). 870–879. 15 indexed citations
4.
Oh, Yun Kyu, et al.. (2019). Relationship between Cardiac Geometry and Serum Hepcidin in Chronic Kidney Disease: Analysis from the KNOW-CKD Study. Journal of Korean Medical Science. 35(1). e2–e2. 4 indexed citations
5.
Lee, Mi Jung, Tae Ik Chang, Joongyub Lee, et al.. (2019). Urine Osmolality and Renal Outcome in Patients with Chronic Kidney Disease: Results from the KNOW-CKD. Kidney & Blood Pressure Research. 44(5). 1089–1100. 20 indexed citations
6.
Chung, Wookyung, Yeong Hoon Kim, Yun Kyu Oh, et al.. (2018). The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study. Journal of Korean Medical Science. 33(53). e322–e322. 8 indexed citations
7.
Nam, Ki Heon, Hyoungnae Kim, Seong Yeong An, et al.. (2018). Circulating Fibroblast Growth Factor-23 Levels are Associated with an Increased Risk of Anemia Development in Patients with Nondialysis Chronic Kidney Disease. Scientific Reports. 8(1). 7294–7294. 36 indexed citations
8.
Choi, Kyu Hun, et al.. (2015). Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib. Journal of Gastroenterology and Hepatology. 3 indexed citations
10.
Choi, Kyu Hun, et al.. (2010). The effects of changing vitamin D levels on anemia in chronic kidney disease patients: a retrospective cohort review. Clinical Nephrology. 74(7). 25–32. 32 indexed citations
11.
Chang, Jae Hyun, Dong Ki Kim, Jung Tak Park, et al.. (2009). Influence of ketoanalogs supplementation on the progression in chronic kidney disease patients who had training on low‐protein diet. Nephrology. 14(8). 750–757. 39 indexed citations
12.
Kim, Dong Ki, Sun-Young Park, Hyunwook Kim, et al.. (2008). A comparison study between mycophenolate mofetil and cyclophosphamide for treatment of proliferative lupus nephritis. The Korean Journal of Internal Medicine. 74(6). 640–647. 1 indexed citations
13.
Park, Hyeong Cheon, Hoon Young Choi, Beom Seok Kim, et al.. (2006). Antiproteinuric Effect of Losartan in Non-Diabetic Renal Disease Is Not Dependent on ACE Insertion/Deletion Polymorphism. Kidney & Blood Pressure Research. 29(4). 216–224. 7 indexed citations
14.
Yoo, Tae‐Hyun, Dong‐Ryeol Ryu, Hyung Jong Kim, et al.. (2005). Clinical Usefulness of Automated Peritoneal Dialysis (APD) in End Stage Renal Disease Patients. Kidney Research and Clinical Practice. 24(2). 280–288.
15.
Chang, Tae Ik, Jung Tak Park, Jung Eun Lee, et al.. (2004). The Comparison of 99mTc-sestamibi SPECT (MIBI) and Echocardiographic Findings between Diabetic and Non-diabetic Patients Starting Dialysis Treatment. Kidney Research and Clinical Practice. 23(4). 577–585. 1 indexed citations
16.
Lee, Ho Yung, Beom Seok Kim, Hoon Young Choi, et al.. (2003). Sclerosing encapsulating peritonitis as a complication of long‐term continuous ambulatory peritoneal dialysis in Korea. Nephrology. 8(s2). S33–9. 41 indexed citations
17.
Choi, Kyu Hun, et al.. (2002). 대한간학회지 제2회 연수강좌 강의록 : 간경변증의 영양관리. Clinical and Molecular Hepatology. 8. 42–47. 1 indexed citations
18.
Choi, Kyu Hun, et al.. (1997). 복합 항암 화학요법 후 HBsAg 양성 악성림프종환자의 임상경과. The Korean Journal of Internal Medicine. 52(4). 542–549. 1 indexed citations
19.
Kim, Yu Seun, Hyeon Joo Jeong, Kyu Hun Choi, et al.. (1996). Renal transplantation in patients with IgA nephropathy.. PubMed. 28(3). 1543–4. 12 indexed citations
20.
Kang, Shin‐Wook, Sang‐Won Lee, Kyu Hun Choi, et al.. (1996). Clinical outcome of HBsAg(+) renal allograft recipients.. PubMed. 28(3). 1653–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026